DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Fralick M, Schneeweiss S, Patorno E.
Risk of diabetic ketoacidosis after initiation of an SGLT2 inhibitor.
N Engl J Med 2017;
376: 2300-2303
We do not assume any responsibility for the contents of the web pages of other providers.